Australia markets close in 26 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
10,776.00+396.00 (+3.82%)
At close: 06:00PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 156.93B
Enterprise value 177.56B
Trailing P/E N/A
Forward P/E 18.35
PEG ratio (5-yr expected) 1.37
Price/sales (ttm)4.45
Price/book (mrq)5.29
Enterprise value/revenue 4.28
Enterprise value/EBITDA 25.25

Trading information

Stock price history

Beta (5Y monthly) 0.12
52-week change 324.35%
S&P500 52-week change 3-8.83%
52-week high 311,000.00
52-week low 38,029.00
50-day moving average 310,326.26
200-day moving average 39,233.71

Share statistics

Avg vol (3-month) 32.72M
Avg vol (10-day) 32.97M
Shares outstanding 51.55B
Implied shares outstanding 6N/A
Float 81.54B
% held by insiders 10.29%
% held by institutions 149.05%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.1
Forward annual dividend yield 42.07%
Trailing annual dividend rate 32.87
Trailing annual dividend yield 30.03%
5-year average dividend yield 43.16
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 424 Feb 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin -2.56%
Operating margin (ttm)15.15%

Management effectiveness

Return on assets (ttm)4.76%
Return on equity (ttm)-4.17%

Income statement

Revenue (ttm)41.49B
Revenue per share (ttm)28.09
Quarterly revenue growth (yoy)55.60%
Gross profit (ttm)27.61B
EBITDA 10.75B
Net income avi to common (ttm)-1.06B
Diluted EPS (ttm)-58.80
Quarterly earnings growth (yoy)-75.30%

Balance sheet

Total cash (mrq)5.82B
Total cash per share (mrq)3.76
Total debt (mrq)32.75B
Total debt/equity (mrq)90.06
Current ratio (mrq)1.00
Book value per share (mrq)23.48

Cash flow statement

Operating cash flow (ttm)7.26B
Levered free cash flow (ttm)2.63B